Since the discovery that our genes hold the keys to our health, the race has been on to find a precise method to edit our genomes. CRISPR provides the tools to precisely edit genomes with unparalleled simplicity and flexibility, resulting in the potential for a revolutionary step towards curing hereditary disorders and correcting mutations that cause cancer. This breakthrough gene editing technology is barely 3 years old, however it has already attracted tens of millions of dollars from investors, inspiring a multitude of exciting biotech start-ups.

Please join Oxford Biotech for what is certain to be an informative and inspiring discussion about how entrepreneurs, academics and industry professionals can join in with the battle to exploit the biggest biotech discovery of the decade.

Attendance is FREE to all OB Members, and tickets are guaranteed to sell out once they are released!